ATE399159T1 - Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung - Google Patents

Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung

Info

Publication number
ATE399159T1
ATE399159T1 AT05802359T AT05802359T ATE399159T1 AT E399159 T1 ATE399159 T1 AT E399159T1 AT 05802359 T AT05802359 T AT 05802359T AT 05802359 T AT05802359 T AT 05802359T AT E399159 T1 ATE399159 T1 AT E399159T1
Authority
AT
Austria
Prior art keywords
silanesters
silaneamids
oxothiazolidine
preventing
carbonic acid
Prior art date
Application number
AT05802359T
Other languages
German (de)
English (en)
Inventor
Karine Lucet-Levannier
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE399159T1 publication Critical patent/ATE399159T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT05802359T 2004-10-21 2005-09-27 Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung ATE399159T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0452399A FR2877004B1 (fr) 2004-10-21 2004-10-21 Esters et amides silaniques d'acide 2-oxothiazolidine-4- carboxylique et leurs utilisations cosmetiques.
US63254104P 2004-12-03 2004-12-03

Publications (1)

Publication Number Publication Date
ATE399159T1 true ATE399159T1 (de) 2008-07-15

Family

ID=34950806

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05802359T ATE399159T1 (de) 2004-10-21 2005-09-27 Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung

Country Status (8)

Country Link
US (1) US7795286B2 (https=)
EP (1) EP1805153B1 (https=)
JP (1) JP5149011B2 (https=)
AT (1) ATE399159T1 (https=)
DE (1) DE602005007764D1 (https=)
ES (1) ES2308565T3 (https=)
FR (1) FR2877004B1 (https=)
WO (1) WO2006045639A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1888510A4 (en) 2005-05-27 2013-01-16 Univ North Carolina NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS
WO2007073560A2 (en) * 2005-12-20 2007-06-28 Rnd Pharmaceuticals, Inc. Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds
FR2921257B1 (fr) 2007-09-21 2009-11-06 Exsymol Sa Utilisation topique de derives thiazolidines contre les consequences du stress oxydatif de la peau
FR2940615B1 (fr) 2008-12-30 2011-12-30 Oreal Association de monosaccharides avec des agents antioxydants et son utilisation en cosmetique
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
US20110229538A1 (en) * 2010-03-17 2011-09-22 Arbonne International Llc Topical skin care composition
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
US9132725B2 (en) 2011-05-09 2015-09-15 Cummins Inc. Vehicle and hybrid drive system
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione
JP7118591B2 (ja) 2017-02-28 2022-08-16 ロレアル レゾルシノール又はその誘導体を含む組成物
JP7412898B2 (ja) 2019-04-26 2024-01-15 ロレアル 特異な粒子と親油性抗酸化剤との組み合わせ
JP7612326B2 (ja) 2019-12-16 2025-01-14 ロレアル 特定の成分の組合せを含む安定な組成物
KR20240099313A (ko) 2021-12-20 2024-06-28 로레알 레티노이드를 포함하는 안정한 조성물
EP4452190A1 (en) 2021-12-20 2024-10-30 L'oreal Stable composition comprising retinoid and ascorbic acid compound
FR3131837B1 (fr) 2022-01-19 2024-10-04 Oreal Composition stable comprenant un rétinoïde et un composé acide ascorbique
FR3131845B1 (fr) 2022-01-19 2024-11-01 Oreal Composition stable comprenant un rétinoïde
CN120359012A (zh) 2022-12-20 2025-07-22 莱雅公司 包含基于透明质酸的聚离子复合物和亲水性或亲脂性抗氧化剂的组合物
FR3145279B1 (fr) 2023-01-30 2026-01-30 Oreal Composition comprenant un complexe polyionique à base d’acide hyaluronique et un antioxydant lipophile
FR3145278B1 (fr) 2023-01-30 2026-04-10 Oreal Composition de dispersion stable comprenant un rétinoïde
WO2024135577A1 (en) 2022-12-23 2024-06-27 L'oreal Stable dispersion composition comprising retinoid
FR3148912B1 (fr) 2023-05-24 2026-02-20 Oreal Composition comprenant des polymères cationiques et anioniques
FR3152226B3 (fr) 2023-08-25 2025-09-19 Oreal Composition cosmétique anhydre pour une application douce et peu grasse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208249A (en) * 1992-08-20 1993-05-04 Clintec Nutrition Co. Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
FR2854160B1 (fr) * 2003-04-25 2005-06-17 Oreal Nouveaux derives heterocycliques de l'acide 2-oxothiazolidine4-carboxylique, utilisation comme agent de photoprotection active

Also Published As

Publication number Publication date
EP1805153B1 (en) 2008-06-25
DE602005007764D1 (de) 2008-08-07
JP5149011B2 (ja) 2013-02-20
US20090074682A1 (en) 2009-03-19
FR2877004A1 (fr) 2006-04-28
JP2008517030A (ja) 2008-05-22
EP1805153A1 (en) 2007-07-11
US7795286B2 (en) 2010-09-14
ES2308565T3 (es) 2008-12-01
WO2006045639A1 (en) 2006-05-04
FR2877004B1 (fr) 2007-03-09

Similar Documents

Publication Publication Date Title
ATE399159T1 (de) Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung
AR038379A1 (es) Esteres de acidos fluoreno-carboxilicos, procedimientos para su preparacion asi como su utilizacion en calidad de medicamentos
CO5611113A2 (es) Tripeptidos que poseen un eter de hidroxiprolina de una quinolina sustituida para la inhibicion de ns3 (hepatitis c)
DE10190550D2 (de) Kosmetische Zusammensetzung
DE602004005886D1 (de) Derivate von n-äphenyl(alkylpiperidin-2-yl)methylübenzamid, verfahren zu deren herstellung und deren anwendung in therapeutika
ATE461259T1 (de) Flüssigkristallines medium mit monofluor- terphenylverbindungen
ATE260272T1 (de) Beta-aminsäure-derivate zur verwendung als matrix-metalloproteasen- und tna-alpha-inhibitoren
MX2009006598A (es) Derivados de sulfamida como transferasa de carnitina palmitoil del higado (l-cptl).
ATE271869T1 (de) Verwendung von thiazolidin- oder pyrrolidinderivaten von aminosäuren als antihyperglykämische mittel
CY1109737T1 (el) Νεα μεθοδος συνθεσης του (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγομελατινης
DE502004004294D1 (de) Verfahren zur herstellung von pyrrolidin-1,2-dicarbonsäure-1 -(phenyl(-amid))-2-(phenyl(-amid)) derivaten und 1-(phenylcarbamoyl)-pyrrolidin-2-carbonsäurederivate als zwischenprodukte
ATE377420T1 (de) Phenylalkansäure- und phenyloxyalkansäure- derivate als hppar aktivatore
MA31346B1 (fr) Formulation liquide injectable de paracetamol
ES555992A0 (es) Procedimiento para la obtencion de e-isomeros de derivados y peptidos de n<-(2-ciano-2-alcoximino-acetil)-aminoacidos
UY29388A1 (es) Derivados del (1,5-difenil-h-pirazol-3-il)oxadiazol, su preparación y su aplicacion en terapéutica.
CO6150166A2 (es) Nuevos derivados de [1,3]tiazolo[4,5-d]pirimidin-2-(3h)-amina 5,7-disustituidos y su uso en terapia
CY1110613T1 (el) Υποκατεστημενες θειαζολες και η χρησιμοποιηση τους για την παρασκευη φαρμακων
BRPI0503700A (pt) artigos absorventes descartáveis
ES472448A1 (es) Procedimiento para la preparacion de nuevas amidas de acidosn-i-(3-benzoilpropil)-4-piperidil)-sulfonicos.
ECSP099339A (es) Derivados de pirrol, su preparación y su utilización en terapéutica
NO20070832L (no) Farmasoytiske preparat av piperazinderivater.
CR8748A (es) Una composicion farmaceutica antimicobacteriana
DOP2006000133A (es) Derivados de 4,5 diarilpiroxol, su preparación y su aplicación en terapeútica
ME00059B (me) Oksidekahidronaftalen modulatori hm74
AR044637A1 (es) Fluorbutenos nematicidas que contienen tiazolina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties